Neuroimaging facilitates the assessment of complementary medicines (CMs) by providing a noninvasive insight into their mechanisms of action in the human brain. This is important for identifying the potential treatment options for target disease cohorts with complex pathophysiologies. The aim of this systematic review was to evaluate study characteristics, intervention efficacy, and the structural and functional neuroimaging methods used in research assessing nutritional and herbal medicines for mild cognitive impairment (MCI) and dementia. Six databases were searched for articles reporting on CMs, dementia, and neuroimaging methods. Data were extracted from 21/2,742 eligible full text articles and risk of bias was assessed. Nine studies exa...
A systematic review was conducted to assess the efficacy and safety of herbal medications (HM), as e...
Abstract Background Elderly individuals who have memo...
Alzheimer's disease (AD) is a progressive brain disorder that gradually impairs the person's memory ...
Neuroimaging facilitates the assessment of complementary medicines (CMs) by providing a noninvasive ...
Neuroimaging facilitates the assessment of complementary medicines (CMs) by providing a noninvasive ...
Neuroimaging facilitates the assessment of complementary medicines (CMs) by providing a noninvasive ...
Abstract Background Subjective cognitive impairment (SCI) substantially increases dementia risk and ...
Mild cognitive impairment (MCI) is a condition that may be prodromal to the development of dementia....
Mild cognitive impairment (MCI) is a condition that may be prodromal to the development of dementia....
Currently, available mainstream approaches used to treat mild cognitive impairment (MCI) and dement...
The treatments of choice in Alzheimer's disease (AD) are cholinesterase inhibitors and NMDA-receptor...
Background: Vitamins and minerals have many functions in the nervous system which are important for ...
Background: Dementia is a global health concern, causing serious health and socioeconomic burdens wi...
The treatments of choice in Alzheimer's disease (AD) are cholinesterase inhibitors and NMDA-receptor...
Background: Dementia is a debilitating syndrome that significantly impacts individuals over the age ...
A systematic review was conducted to assess the efficacy and safety of herbal medications (HM), as e...
Abstract Background Elderly individuals who have memo...
Alzheimer's disease (AD) is a progressive brain disorder that gradually impairs the person's memory ...
Neuroimaging facilitates the assessment of complementary medicines (CMs) by providing a noninvasive ...
Neuroimaging facilitates the assessment of complementary medicines (CMs) by providing a noninvasive ...
Neuroimaging facilitates the assessment of complementary medicines (CMs) by providing a noninvasive ...
Abstract Background Subjective cognitive impairment (SCI) substantially increases dementia risk and ...
Mild cognitive impairment (MCI) is a condition that may be prodromal to the development of dementia....
Mild cognitive impairment (MCI) is a condition that may be prodromal to the development of dementia....
Currently, available mainstream approaches used to treat mild cognitive impairment (MCI) and dement...
The treatments of choice in Alzheimer's disease (AD) are cholinesterase inhibitors and NMDA-receptor...
Background: Vitamins and minerals have many functions in the nervous system which are important for ...
Background: Dementia is a global health concern, causing serious health and socioeconomic burdens wi...
The treatments of choice in Alzheimer's disease (AD) are cholinesterase inhibitors and NMDA-receptor...
Background: Dementia is a debilitating syndrome that significantly impacts individuals over the age ...
A systematic review was conducted to assess the efficacy and safety of herbal medications (HM), as e...
Abstract Background Elderly individuals who have memo...
Alzheimer's disease (AD) is a progressive brain disorder that gradually impairs the person's memory ...